Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia. (Q38015123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

S Anguille

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

V F Van Tendeloo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

2186-2196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2012.145

2 February 2020

exact match

0 references

cites work

Interferon-α in acute myeloid leukemia: an old drug revisited

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Immunotherapy of acute myeloid leukemia: current approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Flt3-ITD mutations can generate leukaemia specific neoepitopes: potential role for immunotherapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Induction of MTG8-specific cytotoxic T-cell lines: MTG8 is probably a tumour antigen that is recognized by cytotoxic T cells in AML1-MTG8-fused gene-positive acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Dysregulated gene expression networks in human acute myelogenous leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Characterization of chronic myeloid leukemia stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Aurora-A kinase: a novel target of cellular immunotherapy for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

The antiapoptotic gene A1/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Cleavage of p21waf1 by proteinase-3, a myeloid-specific serine protease, potentiates cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Bmi1, stem cells, and senescence regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Molecular mechanisms involved in the progression of myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Identification of a survivin-derived peptide that induces HLA-A*0201-restricted antileukemia cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-specific CTL epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Cross-priming of CD8(+) T cells in vivo by dendritic cells pulsed with autologous apoptotic leukemic cells in immunotherapy for elderly patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Expanding the immunotherapeutic potential of minor histocompatibility antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Immunogenicity of Bcl-2 in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Identification of an epitope derived from CML66, a novel tumor-associated antigen expressed broadly in human leukemia, recognized by human leukocyte antigen-A*2402-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Identification of a novel epitope derived from CML66 that is recognized by anti-leukaemia cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Internal tandem duplications of the FLT3 gene are present in leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

BMI-1 is highly expressed in M0-subtype acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Efficient activation of LRH-1-specific CD8+ T-cell responses from transplanted leukemia patients by stimulation with P2X5 mRNA-electroporated dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Expression and prognostic significance of survivin in de novo acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

A tumor suppressor and oncogene: the WT1 story.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

PRAME-Specific Allo-HLA-Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

The coexpression of the apoptosis-related genes bcl-2 and wt1 in predicting survival in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

The t(6;9) associated DEK/CAN fusion protein targets a population of long-term repopulating hematopoietic stem cells for leukemogenic transformation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Identification of HLA-A*0201-presented T-cell epitopes derived from the tumor-associated antigen M-phase phosphoprotein II in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Functional capacity of Mcl-1-specific cytotoxic T-cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

M-phase phosphoprotein 11 is a highly immunogenic tumor antigen in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Identification of a novel peptide derived from the M-phase phosphoprotein 11 (MPP11) leukemic antigen recognized by human CD8+ cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

mRNA expression of MAGE-A3 gene in leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.145

7 January 2021

Identifiers

DOI

10.1038/LEU.2012.145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22652755%20AND%20SRC:MED&resulttype=core&format=json